Home » Topics » Regulatory

Regulatory
RSS

Fujisawa's Prograf cleared by FDA for use in kidney transplantation

May 9, 1997

FDA approves Mylan's generic extended-release diltiazem

May 9, 1997

FDA clears generic antidepressant from Teva

May 7, 1997

ANDA filed for Biovail generic calcium channel blocker

May 7, 1997

Fosamax cleared as preventive medication in osteoporosis

May 7, 1997

SmithKline Beecham's Androderm now available as a single patch system

May 7, 1997

FDA clears generic version of SKB's Compazine

May 6, 1997

Alpharma's Oral Acyclovir Suspension launched in the U.S.

May 2, 1997

Nippon Kayaku reports neuritogenic effects for known compound

May 2, 1997

ESI Lederle launches generic acyclovir

April 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...